ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,846Medicare Part D Prescriptions Filled, Including Refills

Rank: 86 out of 4623

$1.43M Total Retail Price of All Prescriptions

Rank: 48 out of 4623

768 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

18% of this provider’s 768 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 15,458 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
CRESTOR 1,216 993 1 20
METFORMIN HCL 804 660 2 6
LEVOTHYROXINE SODIUM 738 670 3 1
AMLODIPINE BESYLATE 590 551 4 5
ALENDRONATE SODIUM 556 517 5 22
PRAVASTATIN SODIUM 549 454 6 11
NEXIUM 547 432 7 17
JANUVIA 458 411 8 52
LISINOPRIL 381 283 9 4
HYDROCODONE-ACETAMINOPHEN 357 222 S3 10 3
AMLODIPINE BESYLATE-BENAZEPRIL 347 273 11 55
METFORMIN HCL ER 289 236 12 51
ONGLYZA 258 187 13 192
OMEPRAZOLE 243 181 14 7
DIOVAN 243 221 14 39
TAMSULOSIN HCL 241 211 16 29
FUROSEMIDE 228 197 17 8
RAMIPRIL 227 168 18 76
DILTIAZEM 24HR CD 201 197 19 156
ACTOS 193 163 20 87
NIASPAN 184 138 21 110
TRAMADOL HCL 180 139 22 15
CLONIDINE HCL 176 144 23 40
CARVEDILOL 167 147 24 25
KOMBIGLYZE XR 165 136 25 415
BENAZEPRIL HCL 164 162 26 70
CLOPIDOGREL 154 138 27 31
SUCRALFATE 146 120 28 183
AMITRIPTYLINE HCL 143 125 R 29 69
ESCITALOPRAM OXALATE 141 121 30 75
GLYBURIDE 141 103 R 30 59
GLIMEPIRIDE 138 107 32 38
METOPROLOL TARTRATE 135 116 33 9
CIPROFLOXACIN HCL 131 109 34 43
METOPROLOL SUCCINATE 130 102 35 13
HYDROCHLOROTHIAZIDE 128 111 36 10
AMOXICILLIN 128 113 36 95
IBUPROFEN 125 92 38 65
ZOLPIDEM TARTRATE 121 76 39 18
ZETIA 115 105 40 92
JANUMET 114 93 41 136
PLAVIX 105 82 42 45
MUPIROCIN 104 83 43 159
POTASSIUM CHLORIDE 102 96 44 14
SULFAMETHOXAZOLE-TRIMETHOPRIM 101 76 45 68
AVODART 99 86 46 172
LOSARTAN POTASSIUM 99 93 46 21
LEVOFLOXACIN 98 75 48 81
AZITHROMYCIN 97 71 49 33
MELOXICAM 95 52 50 27
SERTRALINE HCL 94 62 51 26
DILTIAZEM ER 94 78 51 179
WARFARIN SODIUM 93 52 53 24
PANTOPRAZOLE SODIUM 89 83 54 35
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 85 55 19
LIDODERM 86 73 55 139
NABUMETONE 85 84 57 188
FLUCONAZOLE 85 67 57 189
ENALAPRIL MALEATE 84 78 59 41
SINGULAIR 81 59 60 83
DONEPEZIL HCL 81 75 60 30
NAPROXEN 80 66 62 63
TERBINAFINE HCL 76 52 63 323
FLUOXETINE HCL 76 57 63 61
MECLIZINE HCL 73 70 65 125
GLIPIZIDE ER 71 62 66 86
FELODIPINE ER 70 67 67 174
VOLTAREN 69 63 68 182
DIGOXIN 68 51 69 58
TRICOR 67 47 70 88
FLUTICASONE PROPIONATE 66 46 71 32
CLARITHROMYCIN 64 48 72 362
FINASTERIDE 62 57 73 109
BYETTA 61 33 74 422
VESICARE 60 44 75 166
LOVAZA 58 34 76 112
SIMVASTATIN 58 54 76 2
BONIVA 56 56 78 314
DIOVAN HCT 56 53 78 67
CEPHALEXIN 55 41 80 84
SPIRONOLACTONE 53 43 81 77
TAZTIA XT 53 48 81 470
GLIPIZIDE 51 50 83 49
DICLOFENAC POTASSIUM 51 47 83 247
BENICAR HCT 51 51 83 203
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 26, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.